Cooperation
Cooperation is at the heart of professionalism. Physicians and other providers, even when in competitive situations, freely share experience and perspective about optimal patient management. Witness the medical literature. No sooner is an innovative therapeutic procedure or diagnostic strategy devised than the originators, without compensation, rush to publish their findings for all the public, including their rivals, to see.
The cooperative approach in health care is exemplified by Quality Improvement Organizations (QIO). QIOs are the performance management tool of the Center for Medicare and Medicaid Services (CMS) overseeing the care of more than 40 million Medicare patients. There are 41 QIOs, a mixture of forprofit and not-for-profit concerns, with a combined annual budget of over $300 million. As an example of their activities, in collaboration with Qualis, the regional QIO, Dellinger, Hauwmann, Bratzler, et al recently described a 27% reduction in surgical wound infections in 35,000 patients at 44 hospitals in Alaska, Idaho and Washington.
2 This performance improvement was due to optimization of antibiotic usage, prevention of hyperglycemia, and maintenance of normothermia during surgery.
Consistent with the mission authorized by Congress in 1992, QIOs originally took an adversarial position in their investigations of physicians and hospitals. Few were pleased with this tact and as a part of the Medicare Prescription Drug Act of 2003, Congress authorized the IOM to review the performance of QIOs. The report suggested that the organizations redirect their energies away from investigation of alleged misconduct and towards a more collegial approach.
3 Elements of such cooperation included establishing infrastructure for voluntary hospital and physician quality initiatives, integration of activities with like-minded organizations such as the National Quality Forum, providing technical resources such as computer support, and eliminating jurisdictional barriers to sharing data between providers.
Industrial Engineering
Quality control and performance improvement tools are a vital part of most industries, especially manufacturing. And business school curricula, the executive press and business consultants all reflect this appropriate emphasis, be it total quality management, continuous quality improvement, lean thinking, balanced scorecard, or Six Sigma.
Though created by Motorola, the best known instrument in medicine, Six Sigma, has become equated with General Electric, perhaps because of GE's commercial success (as the world's second most valuable company) and its familiar face in health care. Six Sigma is designed to minimize industrial defects, limiting errors to less than six standard deviations (hence the name), or less than 3.4 times in a million opportunities. Separated into define, measure, ana-COMMENTARY CME … public disquietude surrounding medical errors has never been greater.
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Improving Health Care Quality: Current Concepts lyze, improve and control functions, this tool is rigorously quantitative and project-oriented. 4 So far, it has been used mostly in clinical engineering or workflow improvements such as streamlining laboratory testing, increasing operating room efficiency, and optimizing pharmacy operations.
Validation and Certification
In addition to the well-established Joint Commission on Accreditation of Healthcare Organizations and the National Committee for Quality Assurance, there are several newcomers in the validation and certification business. These groups, which include the Leapfrog Group and the National Quality Forum, seek to gather, distribute, and promote compliance with the best practices of the day.
The Leapfrog Group was established in 2000 by business leaders in response to the To Err is Human report. From early members such as Boeing, IBM, General Electric, and General Motors, the Group has now expanded to 170 members, responsible for spending $67 billion annually on the health care needs of 36 million employees, dependents and retirees.
In order to promote smart purchasing decisions by their members and other companies, Leapfrog's strategy is to survey hospitals in four different areas and to distribute the results in the public domain. The four quality practices are: 1) computerized physician order entry systems, 2) intensivist staffing of ICUs, 3) referral of surgical patients (eg, esophagectomy, pancreatic resection, abdominal aortic aneurysm repair, percutaneous coronary interventions) to high-volume hospitals, 4) adoption of the 27 National Quality Forum's Safe Practices.
Results of these voluntary surveys in 966 hospitals can be found through an individual hospital search online at the Leapfrog Group Web site: www.leapfrog.com/cp. 5 The National Quality Forum (NQF) was founded in 1999 by Kenneth Kizer, MD, the head of Veterans Affairs health care in the Clinton administration, with the goal of being the standard-setting body for quality in American medicine. With 330 members, the NQF, through a formal voting mechanism, certifies various performance improvement strategies such as those used by Leapfrog. These guidelines in turn originate from groups such as the Ambulatory Care Alliance and the Physician Consortium for Performance Improvement (an offshoot of the American Medical Association).
Examples of NQF Safe Practices include:
• 
Compensation
One of the latest strategies to improve health care quality is pay-forperformance (P4P). No more accolades, or public attention, or professional respect, but hard cash and lots of it.
P4P programs, using bonuses or at-risk pools, seek to improve quality in preventive, acute or chronic care, promote patient satisfaction, and encourage the deployment of information technology.
The director of the CMS, Mark McClellan, MD, has estimated that, by 2012, 20-30% of federal provider payments will be on the basis of P4P. 7 Such programs include Bridges to Excellence, Integrated Healthcare Association, Medicare Physician Group Practice Demonstration and the Premier Group. Of these, the Premier trial is the largest with 260 participating hospitals and, to date, has the greatest financial stakes (eg, a 2% bonus for the top 10% performers; 1% for the next 10%).
Premier, a hospital purchasing alliance headquartered in San Diego, began the CMS-funded project in 2003 focusing on five clinical conditions:
• Table 1 ). 8 So, as a result of all this innovation and hard work, there is lots of good news on the quality front. All the tools-cooperation, industrial engineering, validation and certification, exhortation, compensationhave their proponents, advantages, success stories … and skeptics.
Regarding QIOs, Snyder and Anderson, in the only published controlled study, found no benefit from their activities in stroke, pneumonia and cardiac care in Maryland, Nevada, New York, Utah, and Washington. 9 Six Sigma, for all its value in logistics, has not found a major place in clinical processes such as surgery or interventional therapies. And many in health care have found its project orientation cumbersome to implement and fleeting in benefit.
More than five years after founding of the Leapfrog Group, a recent study found less than 4% of hospitals complying with one of its core tenets, the 24-hour intensivist staffing of ICUs. 10 Before the cheers for IHI's The 100,000 Lives Campaign had quieted, the Wall Street Journal was raising questions about sample bias, attribution and inflated results. 11 Bradley and colleagues found that compliance with P4P-styled treatment strategies for acute myocardial infarction (ie, aspirin, angiotensinconverting enzyme inhibitors, betablockers) only accounted for a 6% variation in 30-day mortality. AMI -acute myocardial infarction; CABG -coronary artery bypass graft; CAPcommunity-acquired pneumonia; HF -heart failure; HIP -hip and knee replacement
Finally, no less an authority than Michael E Porter, Harvard Business School professor and the maven of American management research, regards P4P programs as too process-oriented, micro-managed, simplistic and ponderous. 13 What is the verdict? Which instrument, if any, will be the solution to health care's quality woes? For that answer, just like any other scientific question, these interventions will need to be subjected to the same scrutiny as a new drug, or diagnostic test, or surgical procedure. And, despite all the impatience around the crisis of medical mistakes, that answer is not immediately forthcoming.
This deliberative approach, as necessary and appropriate as it is, exposes perhaps the greatest threats to patient safety … inertia and the status quo. ❖
